HOME >> MEDICINE >> NEWS
Cedars-Sinai Medical News Tips

Welcome to the inaugural edition of Cedars-Sinai Medical Center's "Top Tips." This semi-monthly service is designed especially for health and medical reporters and is offered free of charge by the Cedars-Sinai Medical Center Public Relations Department. To receive "Top Tips" twice each month via e-mail, please send your name, organization, phone and fax numbers, plus e-mail address, to sandy@vancommunications.com. If you are already receiving this service and do not wish to, you may cancel by sending to the same e-mail address with the word "unsubscribe" entered in the subject field. To pursue any of these story ideas, call 1-800-396-1002. Thank you.

DIABETES DRUG AND ACCUTANE BLOCK BREAST CANCER CELL GROWTH
Breast cancer cells exposed to a diabetes drug (Troglitazone) and the Vitamin A compound Accutane stopped multiplying and died on cue in laboratory and animal studies conducted at Cedars-Sinai Medical Center. The drug combination appears to have no adverse effect on healthy cells, either in laboratory studies or in immunodeficient mice injected with human breast cells that form tumors.
Interview: H. Phillip Koeffler, M.D., Director of Hematology/Oncology, Cedars-Sinai

NEW BRAIN TUMOR SUPPORT GROUP OFFERS PATIENTS AND FAMILIES MONTHLY UPDATES ON NEW TREATMENT OPTIONS PLUS PSYCHOLOGICAL SUPPORT
A new Brain Tumor Support Group at Cedars-Sinai Medical Center's Neurosurgical Institute provides patients and their families with psychological support as well as monthly updates on the latest in treatment options, including radiation, chemotherapy and future strategies using gene therapy and immunology. The series of programs combines medical updates with psychological support groups.
Interview: World-renowned brain surgeon Keith L. Black, M.D., and brain tumor patients

CLINICAL TRIALS AT CEDARS-SINAI OFFER NEW OPTION FOR ANGINA PAIN SUFFERERS
Cardiac patients who are t
'"/>

Contact: Sandra Van or Roberta Nichols
sandy@vancommunications.com
1-800-396-1002
Cedars-Sinai Medical Center
27-Aug-1998


Page: 1 2

Related medicine news :

1. Cedars-Sinai medical tipsheet for Dec. 2004
2. Cedars-Sinai October 2004 medical tipsheet
3. Cedars-Sinai Medical tipsheet for May 2004
4. Cedars-Sinai receives full AAHRPP accreditation for all research involving human subjects
5. Cedars-Sinai March medical tipsheet
6. Cedars-Sinai researchers identify a gene that causes insulin resistance in Mexican Americans
7. Medical geneticist at Cedars-Sinai awarded $8.5 million NIH research grant
8. Cedars-Sinai researchers detail events that enable brain tumors to weaken immune system
9. Cedars-Sinai Medical tipsheet for July 2003
10. Cedars-Sinai researchers to present findings at Amerian College of Cardiology Scientific Meeting
11. Patients who need cardiac resynchronization therapy may be eligible for Cedars-Sinai clinical trials

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cedars Sinai Medical News Tips

(Date:11/22/2014)... 22, 2014 Setria® Glutathione is ... approved it for use “as a therapeutically active ... within the Therapeutic Goods (Listing) Notice 2014 (No. ... Hakko’s Setria® Glutathione will be exclusivity distributed in ... sources and imports fine chemicals to Australian manufacturers. ...
(Date:11/22/2014)... PITTSBURGH, PA (PRWEB) November 22, 2014 ... about the pain caused by the machine," said an ... injury, she had to go back a second time ... my invention idea." , She developed the patent-pending MAMO ... for breast cancer. The design saves the patient from ...
(Date:11/22/2014)... Lipitor lawsuits ( http://www.lipitorlawsuitcenter.com/ ) that ... developed Type 2 diabetes due to its use continue ... underway in U.S. District Court, District of South Carolina, ... litigation will convene its next Status Conference on December ... Counsel for Plaintiffs and Defendants to meet and confer, ...
(Date:11/22/2014)... November 22, 2014 The Sports Conflict ... Roy Baroff to its team of conflict resolution professionals. ... player, coach, and referee. He has over 30 years experience ... beyond. , “I'm very excited to connect with SCI and ... related interests to a program with a complete sports focus,” ...
(Date:11/22/2014)... (PRWEB) November 22, 2014 Wright & ... AndroGel side-effects lawsuits have been scheduled between October ... Northern District of Illinois. U.S. District Judge Matthew F. ... a Case Management Order (CMO) on November 6, 2014 ... for attorneys to submit documents and other activities in ...
Breaking Medicine News(10 mins):Health News:Setria® Glutathione Now Available in Australia 2Health News:Setria® Glutathione Now Available in Australia 3Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 3Health News:SCI Announces New Team Member Roy Baroff 2Health News:SCI Announces New Team Member Roy Baroff 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 4
(Date:11/22/2014)... 2014 Many power shifts are occurring ... of patients in the biopharmaceutical market is impacting ... than ever, understanding how to effectively acquire, convert, ... essential. According to recent research ... spent about two-thirds of their patient-focused dollars on ...
(Date:11/21/2014)... Nov. 21, 2014 In September 2014, the ... carried out a new product development plan that started ... "limited edition" lab coat , aptly named "Vera ... surgery in the world. The new women,s designer lab ... with a sleek envelope collar, vertical princess and high ...
(Date:11/21/2014)... , Nov. 21, 2014  PTC Therapeutics, Inc. (NASDAQ: ... 2014 Legend of Technology Award for Vision, Innovation, and Leadership ... Chief Executive Officer. This award recognizes an individual who has ... New Jersey for several decades. ... Award," stated Stuart Peltz , Ph.D., CEO of PTC ...
Breaking Medicine Technology:New Report Details Importance of Adopting a "Patient Journey" Framework in Marketing 2Medelita Introduces Medical Industry's First Limited Edition Women's Designer Lab Coat 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 3
Cached News: